Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
385.00    -7.50 (-1.91%)
Bid:
380.00
Ask:
390.00
Spread: 10.00 (2.632%)
Market Cap: £184.79m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Acquisition

29 Aug 2006 07:01

Tristel PLC29 August 2006 For release29 August 2006 Tristel Plc Technology Acquisition Agreement with IVC Limited, New Zealand Tristel plc ("Tristel"), the chlorine dioxide specialist that supplies infectionand contamination control products to healthcare and institutionalestablishments and the pharmaceutical and food processing industries, announcesthat it has entered into a technology acquisition agreement with IVC Limited, ("IVC"). IVC is Tristel's New Zealand distributor and its principal shareholderis Mark Fraundorfer, an internationally renowned Urologist. Under the terms of the agreement IVC transfers to Tristel the design and patentrights to two inventions which it has created to work specifically withTristel's chlorine dioxide chemistry. The inventions are a sterilizing traysystem which enables single use decontamination of endoscopic equipment and ahygiene work station which enables Tristel's highly effective sporicidalchemistry to be easily applied to floors and walls in high risk wards anddepartments of hospitals. IVC has funded the design and development process to date and transfers theintellectual property created in return for unspecified future royalties. Commenting upon the agreement, Paul Swinney, Chief Executive of Tristel, said: "Outside of the most advanced healthcare markets, where endoscopes are mainlyprocessed in sophisticated and costly automated machines, the majority ofendoscopes are disinfected in basic trays and sinks. These can only holddisinfectant liquids that have to be used repeatedly for many instruments over aperiod of many hours or even days. "The Tristel tray system, combined with Tristel's novel burstable sachet,Tristel Fusion, enables the disinfectant to be used once and to be dedicated toone instrument only. "This achieves one of the key features of the most sophisticated endoscopereprocessing machines at a fraction of their cost, and will help Tristelpenetrate many overseas markets with its chlorine dioxide disinfectants." Tristel plc Parkgreen Communications Ltd Paul Swinney, Chief Executive Paul McManusPaul Barnes, Finance Director Tel 020 7493 3716Tel: 01638 721 500 Mob: 07980 541 893http://www.tristel.com paul.mcmanus@parkgreenmedia.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Jan 20137:00 amRNSPeer-reviewed published articles
11th Dec 201212:56 pmRNSResult of AGM
29th Oct 20127:00 amRNSFinal Results
29th Aug 20127:00 amRNSDirector/PDMR Shareholding
8th Aug 20127:00 amRNSDirectorate Change
2nd Aug 20127:00 amRNSNew website
23rd Jul 201210:29 amRNSDirector/PDMR Shareholding
23rd Jul 20127:00 amRNSTrading update
9th Jul 20127:00 amRNSSupply&distribution agreement - Basan Germany GmbH
25th Jun 20127:00 amRNSDirectorate Change
15th Jun 201211:40 amRNSDirectors' Shareholdings
15th Jun 20127:00 amRNSTrading Update
12th Jun 20127:00 amRNSResult of Clinical Study
30th Apr 20129:00 amRNSDirectors' Dealings
3rd Apr 20127:00 amRNSTermination of supply arrangement
30th Mar 20127:00 amRNSResults of Clinical Study
12th Mar 20127:00 amRNSHalf Yearly Report
8th Mar 20127:00 amRNSNotice of Results
11th Jan 20123:17 pmRNSDirector/PDMR Shareholding
4th Jan 20128:50 amRNSDirector/PDMR Shareholding
23rd Dec 201112:16 pmRNSDirector/PDMR Shareholding
21st Dec 20113:40 pmRNSGrant of Share Options
13th Dec 201111:52 amRNSResult of AGM
8th Dec 20114:24 pmRNSDirector/PDMR Shareholding
25th Nov 20111:22 pmRNSDirector/PDMR Shareholding
22nd Nov 20117:00 amRNSDirector's Dealing
11th Nov 201110:27 amRNSDirector/PDMR Shareholding
4th Nov 20112:10 pmRNSDirector/PDMR Shareholding
24th Oct 20119:51 amRNSDirector/PDMR Shareholding
24th Oct 20117:01 amRNSDirectorate Change
24th Oct 20117:00 amRNSFinal Results
7th Sep 20117:00 amRNSFull regulatory approval for Fuse and Jet in China
9th Aug 20118:37 amRNSDirector's Shareholding
8th Aug 20117:00 amRNSCash inflow regarding R&D spend
25th Jul 20117:00 amRNSTrading update & notice of results
6th Jun 20117:00 amRNSApproval for Wipes System from VAH in Germany
12th May 20118:00 amRNSChina Licence received
6th May 20117:00 amRNSDirector Dealing
4th May 20112:38 pmRNSDirector Dealing
4th May 20117:00 amRNSDirector/PDMR Shareholding
28th Apr 20112:08 pmRNSTrading Update
14th Mar 20117:00 amRNSHalf Yearly Report
31st Jan 20117:00 amRNSCompletion of Clean Room & Notice of Results
30th Dec 20107:00 amRNSTermination of Agreement with Clorox
14th Dec 201011:15 amRNSResult of AGM
22nd Nov 201010:12 amRNSResult of General Meeting
12th Nov 201010:55 amRNSDirector/PDMR Shareholding
8th Nov 20103:06 pmRNSDirector Shareholding
5th Nov 201011:32 amRNSPlacing to raise £3.9million
18th Oct 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.